Home \ VISAVET \ Units \ Clinical Trials Unit


Contact

Clinical Trials Unit
VISAVET Health Surveillance Centre
Universidad Complutense
Av. Puerta de Hierro s/n. 28040 Madrid. Spain

e-mail Clinical Trials Unit


Head office phone: (+34) 913 944 096

Fax: (+34) 913 943 795


SEC
The Unit for Clinical Trials (SEC) is in charge of the design, management and coordination of the field studies involving the use of experimental animals, both for studies of VISAVET or other public or private research centers o companies. Furthermore, SEC promotes animal welfare during the trials and ensure compliance with the experimental protocols to reach the objectives of the studies. Regarding the research activities, SEC is focused on the development of experimental models, including in vitro alternatives, for the evaluation of different biologics for Animal Health, mainly diagnosis reactives and vaccines. In this sense, SEC develop studies about natural transmission models of infection and indicators of efficacy and protection using different immunological techniques and novel systems for the evaluation of the pathogenicity and virulence of the microorganisms.

Investigation

Publicaciones científicas

Last scientific publications:


Outreach

Tesis

Last outreach publications:




Comunicaciones





Staff

Head of unit

Javier Bezos Garrido

Senior Lecturer MINECO
PhD in Veterinary Sciences

Head of laboratory

Teresa García-Seco Romero
PhD in Veterinary Sciences
Carmen Bárcena Asensio
PhD in Veterinary Sciences
Alberto Antoine Díez Guerrier

Alberto Antoine Díez Guerrier

Assistant Professor UCM
Degree in Veterinary Medicine (DVM)

publiDB
SEC Science Publication Indicators
ISI Publications
Total
7
Last 12 mo.
3
Last 60 mo.
7
In Press
-
Citations
Impact Factor av.
1.747
I.F. last 12 mo.
1.717
I.F. last 60 mo.
1.747
Mode quartile
1


Categories
Total Quartile
Veterinary Sciences 6 1
New Journal. Impact Factor not available 1 0
Immunology 0 4
Microbiology 0 3

SEC Outreach Publication Indicators
Publications
Total
2
Last 12 mo.
2
Last 60 mo.
2
Communications
Total
5
Last 12 mo.
1
Last 60 mo.
5